{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T05:35:15Z","timestamp":1793338515469,"version":"4.5.0"},"reference-count":103,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100020405","name":"Holy House of Mercy of Lisbon","doi-asserted-by":"publisher","award":["MB35-2021"],"award-info":[{"award-number":["MB35-2021"]}],"id":[{"id":"10.13039\/501100020405","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009045","name":"Uniwersytet Jagiello\u0144ski Collegium Medicum","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009045","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UK Research and Innovation Medical Research Council","doi-asserted-by":"publisher","award":["MR\/V033964\/1"],"award-info":[{"award-number":["MR\/V033964\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"National Science Centre Poland","doi-asserted-by":"publisher","award":["2019\/34\/E\/NZ7\/00454"],"award-info":[{"award-number":["2019\/34\/E\/NZ7\/00454"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.neurot.2025.e00774","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T23:16:48Z","timestamp":1762211808000},"page":"e00774","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Sigma-1-targeting multimodal compound HBK-15 reverses memory deficits and restores hippocampal plasticity under NMDA hypofunction"],"prefix":"10.1016","volume":"23","author":[{"given":"Kinga","family":"Sa\u0142aciak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaudia","family":"Lustyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika","family":"Jagielska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Szafarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Inteiro-Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jos\u00e9","family":"Di\u00f3genes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Xapelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Schnur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Morton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuzo","family":"Sakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Crouzier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Meunier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Delprat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tangui","family":"Maurice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Pytka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurot.2025.e00774_bib1","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.2147\/NDT.S199746","article-title":"Cognitive impairment in depression: recent advances and novel treatments","volume":"15","author":"Perini","year":"2019","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00774_bib2","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1176\/ajp.153.3.321","article-title":"What are the functional consequences of neurocognitive deficits in schizophrenia?","volume":"153","author":"Green","year":"1996","journal-title":"Am J Psychiatr"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00774_bib3","doi-asserted-by":"crossref","first-page":"455","DOI":"10.31887\/DCNS.2013.15.4\/cpittenger","article-title":"Disorders of memory and plasticity in psychiatric disease","volume":"15","author":"Pittenger","year":"2013","journal-title":"Dialogues Clin Neurosci"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00774_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/nu14050917","article-title":"Emerging evidence for the widespread role of glutamatergic dysfunction in neuropsychiatric diseases","volume":"14","author":"McGrath","year":"2022","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00774_bib5","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1038\/npp.2015.310","article-title":"Limbach L.,et al. State-dependent partial occlusion of cortical LTP-like plasticity in major depression","volume":"41","author":"Kuhn","year":"2016","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00774_bib6","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.biopsych.2020.06.027","article-title":"Sigvard A.,et al. Associations between cognitive function and levels of glutamatergic metabolites and gamma-aminobutyric acid in antipsychotic-na\u00efve patients with schizophrenia or psychosis","volume":"89","author":"Bojesen","year":"2021","journal-title":"Biol Psychiatry"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00774_bib7","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1038\/npp.2013.126","article-title":"Martin D.,et al. Neuroplasticity in depressed individuals compared with healthy controls","volume":"38","author":"Player","year":"2013","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00774_bib8","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/s41380-018-0252-9","article-title":"Glutamatergic neurometabolite levels in major depressive disorder: a systematic review and meta-analysis of proton magnetic resonance spectroscopy studies","volume":"24","author":"Moriguchi","year":"2019","journal-title":"Mol Psychiatr"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00774_bib9","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1093\/schbul\/sbs010","article-title":"NMDA receptor hypofunction, parvalbumin-positive neurons, and cortical gamma oscillations in schizophrenia","volume":"38","author":"Gonzalez-Burgos","year":"2012","journal-title":"Schizophr Bull"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00774_bib10","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.pnpbp.2008.10.005","article-title":"Reduced levels of NR2A and NR2B subunits of NMDA receptor and PSD-95 in the prefrontal cortex in major depression","volume":"33","author":"Feyissa","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00774_bib11","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nrn2911","article-title":"Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders","volume":"11","author":"Hardingham","year":"2010","journal-title":"Nat Rev Neurosci"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00774_bib12","doi-asserted-by":"crossref","first-page":"111217","DOI":"10.1016\/j.celrep.2022.111217","article-title":"Trafficking of NMDA receptors is essential for hippocampal synaptic plasticity and memory consolidation","volume":"40","author":"Yang","year":"2022","journal-title":"Cell Rep"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00774_bib13","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1177\/02698811211008560","article-title":"Sustained NMDA receptor hypofunction impairs brain-derived neurotropic factor signalling in the PFC, but not in the hippocampus, and disturbs PFC-dependent cognition in mice","volume":"35","author":"Tanqueiro","year":"2021","journal-title":"J Psychopharmacol"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00774_bib14","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0014-2999(90)90186-A","article-title":"N-methyl-D-aspartate-induced neuronal activation is selectively modulated by \u03c3 receptors","volume":"179","author":"Monnet","year":"1990","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00774_bib15","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.tips.2016.01.003","article-title":"The Sigma-1 receptor as a pluripotent modulator in living systems","volume":"37","author":"Su","year":"2016","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00774_bib16","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0006-8993(94)91397-8","article-title":"Nabeshima T.Behavioral evidence for a modulating role of \u03c3 ligands in memory processes. I. Attenuation of dizocilpine (MK-801)-induced amnesia","volume":"647","author":"Maurice","year":"1994","journal-title":"Brain Res"},{"key":"10.1016\/j.neurot.2025.e00774_bib17","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.neubiorev.2021.10.037","article-title":"Revisiting the sigma-1 receptor as a biological target to treat affective and cognitive disorders","volume":"132","author":"Sa\u0142aciak","year":"2022","journal-title":"Neurosci Biobehav Rev"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00774_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142499","article-title":"Kazek G.,et al. Antidepressant- and anxiolytic-like effects of new dual 5-HT1A and 5-HT7 antagonists in animal models","volume":"10","author":"Pytka","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.neurot.2025.e00774_bib19","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.pnpbp.2017.07.013","article-title":"Grybo\u015b A.,et al. HBK-14 and HBK-15, triple 5-HT 1A , 5-HT 7 and 5-HT 3 antagonists with potent antidepressant- and anxiolytic-like properties, increase seizure threshold in various seizure tests in mice","volume":"79","author":"Pytka","year":"2017","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00774_bib20","first-page":"3931","article-title":"Walczak M.Single administration of HBK-15-a Triple 5-HT1A, 5-HT7, and 5-HT3 receptor antagonist-reverses depressive-like behaviors in mouse model of depression induced by corticosterone","volume":"55","author":"Pytka","year":"2018","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.neurot.2025.e00774_bib21","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.bbr.2017.06.032","article-title":"Waszkielewicz A.,et al. HBK-15 protects mice from stress-induced behavioral disturbances and changes in corticosterone, BDNF, and NGF levels","volume":"333","author":"Pytka","year":"2017","journal-title":"Behav Brain Res"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00774_bib22","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/cbdd.12394","article-title":"Synthesis and evaluation of antidepressant-like activity of some 4-Substituted 1-(2-methoxyphenyl)Piperazine derivatives","volume":"85","author":"Waszkielewicz","year":"2015","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.neurot.2025.e00774_bib23","first-page":"7","article-title":"Zygmunt M.,et al. Chemically homogenous compounds with antagonistic properties at all \u03b11-Adrenoceptor subtypes but not \u03b21-Adrenoceptor attenuate adrenaline-induced arrhythmia in rats","author":"Pytka","year":"2016","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.neurot.2025.e00774_bib24","doi-asserted-by":"crossref","unstructured":"Pytka K., Sa\u0142aciak K., Jagielska A., Lustyk K., G\u0142uch-Lutwin M., Mordyl B., et al. HBK-15 bypasses BDNF via ERK1\/2-biased 5-HT1A receptor signaling to deliver a rapid antidepressant-like effect. 2025.","DOI":"10.21203\/rs.3.rs-7315313\/v1"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00774_bib25","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s11011-016-9932-9","article-title":"HBK-14 and HBK-15 with antidepressant-like and\/or memory-enhancing properties increase serotonin levels in the hippocampus after chronic treatment in mice","volume":"32","author":"Pytka","year":"2017","journal-title":"Metab Brain Dis"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00774_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165495","article-title":"HBK-14 and HBK-15 do not influence blood pressure, lipid profile, glucose level, or liver enzymes activity after chronic treatment in rats","volume":"11","author":"Pytka","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.neurot.2025.e00774_bib27","first-page":"7","article-title":"Chemically homogenous compounds with antagonistic properties at all \u03b11-Adrenoceptor subtypes but not \u03b21-Adrenoceptor attenuate adrenaline-induced arrhythmia in rats","author":"Pytka","year":"2016","journal-title":"Front Pharmacol"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00774_bib28","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.biopsych.2012.10.027","article-title":"Recollection and familiarity in schizophrenia: a quantitative review","volume":"73","author":"Libby","year":"2013","journal-title":"Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00774_bib29","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/schbul\/sbr146","article-title":"3rd.et al. Relational and Item-Specific Encoding (RISE): task development and psychometric characteristics","volume":"38","author":"Ragland","year":"2012","journal-title":"Schizophr Bull"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00774_bib30","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/sj.bjp.0706927","article-title":"The anti-amnesic and neuroprotective effects of donepezil against amyloid beta25-35 peptide-induced toxicity in mice involve an interaction with the sigma1 receptor","volume":"149","author":"Meunier","year":"2006","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00774_bib31","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0022-3565(24)38131-5","article-title":"Molecular and ligand-binding characterization of the sigma-receptor in the Jurkat human T lymphocyte cell line","volume":"289","author":"Ganapathy","year":"1999","journal-title":"J Pharmacol Exp Therapeut"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00774_bib32","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1471-4159.1982.tb10868.x","article-title":"The binding of [3H]AMPA, a structural analogue of glutamic acid, to rat brain membranes","volume":"38","author":"Honor\u00e9","year":"1982","journal-title":"J Neurochem"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00774_bib33","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0014-2999(91)90063-V","article-title":"Hurt S.D.,et al. [3H]CGP 39653: a new N-methyl-D-aspartate antagonist radioligand with low nanomolar affinity in rat brain","volume":"192","author":"Sills","year":"1991","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00774_bib34","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0014-2999(96)00477-3","article-title":"Binding of the radiolabeled glycine site antagonist [3H]MDL 105,519 to homomeric NMDA-NR1a receptors","volume":"312","author":"Siegel","year":"1996","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00774_bib35","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1073\/pnas.86.2.740","article-title":"Interaction of [3H]MK-801 with multiple states of the N-methyl-D-aspartate receptor complex of rat brain","volume":"86","author":"Javitt","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00774_bib36","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0014-2999(90)90539-I","article-title":"Binding of [3H]ifenprodil, a novel NMDA antagonist, to a polyamine-sensitive site in the rat cerebral cortex","volume":"176","author":"Schoemaker","year":"1990","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00774_bib37","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/j.1476-5381.1996.tb15529.x","article-title":"Characterization of a human 5-hydroxytryptamine3 receptor type A (h5-HT3R-AS) subunit stably expressed in HEK 293 cells","volume":"118","author":"Hope","year":"1996","journal-title":"Br J Pharmacol"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00774_bib38","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s11064-005-2681-5","article-title":"Masuko T.et al. Characteristics of omega-conotoxin GVI A and MVIIC binding to Cav 2.1 and Cav 2.2 channels captured by anti-Ca2+ channel peptide antibodies","volume":"30","author":"Ichida","year":"2005","journal-title":"Neurochem Res"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00774_bib39","doi-asserted-by":"crossref","first-page":"5768","DOI":"10.1074\/jbc.271.10.5768","article-title":"The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel","volume":"271","author":"Gee","year":"1996","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00774_bib40","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0022-3565(25)24904-7","article-title":"(-)-[3H] desmethoxyverapamil labels multiple calcium channel modulator receptors in brain and skeletal muscle membranes: differentiation by temperature and dihydropyridines","volume":"237","author":"Reynolds","year":"1986","journal-title":"J Pharmacol Exp Therapeut"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00774_bib41","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1046\/j.1471-4159.2000.0752590.x","article-title":"Characterization of [(3)H]Quisqualate binding to recombinant rat metabotropic glutamate 1a and 5a receptors and to rat and human brain sections","volume":"75","author":"Mutel","year":"2000","journal-title":"J Neurochem"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00774_bib42","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0028-3908(99)00053-2","article-title":"[3H]-LY341495 as a novel antagonist radioligand for group II metabotropic glutamate (mGlu) receptors: characterization of binding to membranes of mGlu receptor subtype expressing cells","volume":"38","author":"Johnson","year":"1999","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00774_bib43","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cell.2007.08.036","article-title":"Sigma-1 receptor chaperones at the ER- mitochondrion interface regulate Ca2+ signaling and cell survival","volume":"131","author":"Hayashi","year":"2007","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00774_bib44","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/ptr.8068","article-title":"Schmitt M.,et al. Convolamine, a tropane alkaloid extracted from Convolvulus plauricalis, is a potent sigma-1 receptor-positive modulator with cognitive and neuroprotective properties","volume":"38","author":"Crouzier","year":"2024","journal-title":"Phytother Res"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00774_bib45","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.1016\/j.apsb.2024.06.013","article-title":"Delprat B.,et al. Amylovis-201 is a new dual-target ligand, acting as an anti-amyloidogenic compound and a potent agonist of the \u03c31 chaperone protein","volume":"14","author":"Garc\u00eda-Pupo","year":"2024","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00774_bib46","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0166-4328(88)90157-X","article-title":"A new one-trial test for neurobiological studies of memory in rats. 1: behavioral data","volume":"31","author":"Ennaceur","year":"1988","journal-title":"Behav Brain Res"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00774_bib47","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1038\/nprot.2013.155","article-title":"Schumann-Bard P.,et al. Object recognition test in mice","volume":"8","author":"Leger","year":"2013","journal-title":"Nat Protoc"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00774_bib48","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0023-9690(81)90020-5","article-title":"Spatial localization does not require the presence of local cues","volume":"12","author":"Morris","year":"1981","journal-title":"Learn Motiv"},{"issue":"5868","key":"10.1016\/j.neurot.2025.e00774_bib49","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/297681a0","article-title":"O\u2019Keefe J.Place navigation impaired in rats with hippocampal lesions","volume":"297","author":"Morris","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.neurot.2025.e00774_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2023.114365","article-title":"Vortioxetine improved negative and cognitive symptoms of schizophrenia in subchronic MK-801 model in rats","volume":"444","author":"Bozkurt","year":"2023","journal-title":"Behav Brain Res"},{"issue":"1\u20133","key":"10.1016\/j.neurot.2025.e00774_bib51","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.schres.2015.06.008","article-title":"Effect of lurasidone dose on cognition in patients with schizophrenia: Post-hoc analysis of a long-term, double blind continuation study","volume":"166","author":"Harvey","year":"2015","journal-title":"Schizophr Res"},{"key":"10.1016\/j.neurot.2025.e00774_bib52","series-title":"Paxinos and Franklin's the mouse brain in stereotaxic coordinates. 5th editio","author":"Paxinos","year":"2019"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00774_bib53","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1016\/j.ymthe.2024.08.022","article-title":"Alem\u00e3n-Serrano N.,et al. A small TAT-TrkB peptide prevents BDNF receptor cleavage and restores synaptic physiology in Alzheimer\u2019s disease","volume":"32","author":"Fonseca-Gomes","year":"2024","journal-title":"Mol Ther"},{"key":"10.1016\/j.neurot.2025.e00774_bib54","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1146\/annurev-neuro-062111-150444","article-title":"Mechanisms of gamma oscillations","volume":"35","author":"Buzs\u00e1ki","year":"2012","journal-title":"Annu Rev Neurosci"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00774_bib55","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0896-6273(02)00586-X","article-title":"Theta oscillations in the hippocampus","volume":"33","author":"Buzs\u00e1ki","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.neurot.2025.e00774_bib56","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrn.2016.21","article-title":"Rhythms of the hippocampal network","author":"Colgin","year":"2016","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00774_bib57","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0165-0173(83)90037-1","article-title":"Cellular bases of hippocampal EEG in the behaving rat","volume":"287","author":"Buzs\u00e1ki","year":"1983","journal-title":"Brain Res"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00774_bib58","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nrn2979","article-title":"The role of phase synchronization in memory processes","volume":"12","author":"Fell","year":"2011","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00774_bib59","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.tics.2019.12.006","article-title":"Theta oscillations in human memory","volume":"24","author":"Herweg","year":"2020","journal-title":"Trends Cogn Sci"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00774_bib60","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.psychres.2005.11.011","article-title":"Neurocognitive deficits and disability in major depressive disorder","volume":"145","author":"Jaeger","year":"2006","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.neurot.2025.e00774_bib61","first-page":"11","article-title":"The alternate-form reliability study of six variants of the Brief Visual-Spatial Memory Test-Revised and the Hopkins Verbal learning test-revised","author":"Cai","year":"2023","journal-title":"Front Public Health"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00774_bib62","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1176\/appi.ajp.2007.07010042","article-title":"Cohen J.D.,et al. The MATRICS consensus cognitive battery, part 1: test selection, reliability, and validity","volume":"165","author":"Nuechterlein","year":"2008","journal-title":"Am J Psychiatr"},{"key":"10.1016\/j.neurot.2025.e00774_bib63","article-title":"Vortioxetine for cognitive enhancement in major depression: from animal models to clinical research","author":"Bennabi","year":"201910771","journal-title":"Front Psychiatry"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00774_bib64","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.2174\/1570159X21666230727140843","article-title":"Topa P.A.,et al. Cognitive effects of lurasidone and cariprazine: a mini systematic review","volume":"21","author":"Olivola","year":"2023","journal-title":"Curr Neuropharmacol"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00774_bib65","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1021\/jm101459g","article-title":"Jensen K.G.,et al. Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder","volume":"54","author":"Bang-Andersen","year":"2011","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00774_bib66","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1124\/jpet.110.167346","article-title":"Tagashira R.,et al. Pharmacological profile of lurasidone, a novel antipsychotic agent with potent 5-Hydroxytryptamine 7 (5-HT7) and 5-HT1A receptor activity","volume":"334","author":"Ishibashi","year":"2010","journal-title":"J Pharmacol Exp Therapeut"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00774_bib67","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.euroneuro.2013.08.003","article-title":"Effect of lurasidone on neurocognitive performance in patients with schizophrenia: a short-term placebo- and active-controlled study followed by a 6-month, double blind extension","volume":"23","author":"Harvey","year":"2013","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.neurot.2025.e00774_bib68","article-title":"Glutamatergic dysfunction and glutamatergic compounds for major psychiatric disorders: evidence from clinical neuroimaging studies","author":"Li","year":"20199767","journal-title":"Front Psychiatr"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00774_bib69","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0014-2999(97)83020-8","article-title":"SA4503, a novel cognitive enhancer with \u03c31 receptor agonist properties, facilitates NMDA receptor-dependent learning in mice","volume":"328","author":"Maurice","year":"1997","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00774_bib70","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0014-2999(01)01436-4","article-title":"Beneficial effect of the \u03c31 receptor agonist PRE-084 against the spatial learning deficits in aged rats","volume":"431","author":"Maurice","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neurot.2025.e00774_bib71","doi-asserted-by":"crossref","first-page":"105803","DOI":"10.1016\/j.biocel.2020.105803","article-title":"PRE-084 as a tool to uncover potential therapeutic applications for selective sigma-1 receptor activation","volume":"126","author":"Motawe","year":"2020","journal-title":"Int J Biochem Cell Biol"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00774_bib72","doi-asserted-by":"crossref","DOI":"10.4172\/2378-5756.1000417","article-title":"Effects of fluvoxamine on cognitive function in outpatients with depression in remission: results of an open-label pilot study","volume":"20","author":"Bobrov","year":"2017","journal-title":"J Psychiatry"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00774_bib73","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/hup.1106","article-title":"Cognition and depression: the effects of fluvoxamine, a sigma-1 receptor agonist, reconsidered","volume":"25","author":"Hindmarch","year":"2010","journal-title":"Hum Psychopharmacol Clin Exp"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00774_bib74","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1001\/archpsyc.1993.01820130046008","article-title":"A comparison of Fluvoxamine, cognitive therapy, and placebo in the treatment of panic disorder","volume":"50","author":"Black","year":"1993","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00774_bib75","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1176\/appi.ajp.161.5.826","article-title":"Potter W.Z.,et al. Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [ 11C]DASB positron emission tomography study","volume":"161","author":"Meyer","year":"2004","journal-title":"Am J Psychiatr"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00774_bib76","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.biopsych.2007.04.001","article-title":"Naganawa M.,et al. High occupancy of Sigma-1 receptors in the human brain after single oral administration of Fluvoxamine: a positron emission tomography study using [11C]SA4503","volume":"62","author":"Ishikawa","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.neurot.2025.e00774_bib77","doi-asserted-by":"crossref","unstructured":"M\u00fcller W., Siebert B., Holoubek G., Gentsch C. Neuropharmacology of the anxiolytic drug opripramol, a sigma site ligand. Pharmacopsychiatry 2004;37(S 3):189\u2013197.","DOI":"10.1055\/s-2004-832677"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00774_bib78","doi-asserted-by":"crossref","first-page":"279","DOI":"10.9758\/cpn.2016.14.3.279","article-title":"Differential effects of olanzapine and haloperidol on MK-801-induced memory impairment in mice","volume":"14","author":"Song","year":"2016","journal-title":"Clinical Psychopharmacology and Neuroscience"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00774_bib79","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00213-007-1042-2","article-title":"Pittman B.,et al. Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of \u0394-9-tetrahydrocannabinol in humans","volume":"198","author":"D\u2019Souza","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00774_bib80","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/sj.npp.1301499","article-title":"Murthy A.,et al. Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: Significant Placebo\/Practice effects in a 12-Week, randomized, double blind placebo-controlled trial","volume":"33","author":"Keefe","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00774_bib81","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.jagp.2018.05.008","article-title":"Andrews H.,et al. Donepezil treatment in patients with depression and cognitive impairment on stable antidepressant treatment: a randomized controlled trial","volume":"26","author":"Devanand","year":"2018","journal-title":"Am J Geriatr Psychiatr"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00774_bib82","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s11064-022-03802-x","article-title":"Weso\u0142owska A.,et al. HBK-15, a multimodal compound, showed an anxiolytic-like effect in rats","volume":"48","author":"Lustyk","year":"2023","journal-title":"Neurochem Res"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00774_bib83","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.bbr.2011.01.034","volume":"220","author":"Horisawa","year":"2011","journal-title":"Behav Brain Res"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00774_bib84","doi-asserted-by":"crossref","first-page":"344","DOI":"10.2174\/157015908787386113","article-title":"Pharmacology and therapeutic potential of Sigma1 receptor ligands","volume":"6","author":"Cobos","year":"2008","journal-title":"Curr Neuropharmacol"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00774_bib85","doi-asserted-by":"crossref","first-page":"5346","DOI":"10.1016\/j.apsb.2025.04.028","article-title":"Yang H.,et al. Discovery and proof-of-concept study of a novel highly selective sigma-1 receptor agonist for antipsychotic drug development","volume":"15","author":"Tang","year":"2025","journal-title":"Acta Pharm Sin B"},{"issue":"1\u20132","key":"10.1016\/j.neurot.2025.e00774_bib86","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0006-8993(01)02596-3","article-title":"DOI, a 5-HT2A\/2C receptor agonist, attenuates clozapine-induced cortical dopamine release","volume":"907","author":"Ichikawa","year":"2001","journal-title":"Brain Res"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00774_bib87","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1038\/npp.2011.139","article-title":"Rea W.R.,et al. Acute nicotine-induced tachyphylaxis is differentially manifest in the limbic system","volume":"36","author":"Zuo","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00774_bib88","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nn1846","article-title":"Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory","volume":"10","author":"Vijayraghavan","year":"2007","journal-title":"Nat Neurosci"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00774_bib89","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/17460441.2021.1838483","article-title":"Bi-phasic dose response in the preclinical and clinical developments of sigma-1 receptor ligands for the treatment of neurodegenerative disorders","volume":"16","author":"Maurice","year":"2021","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.neurot.2025.e00774_bib90","doi-asserted-by":"crossref","first-page":"112067","DOI":"10.1016\/j.bbr.2019.112067","article-title":"Sevostjanovs E.,et al. Effects of the N-methyl-d-aspartate receptor antagonist, MK-801, on spatial memory and influence of the route of administration","volume":"372","author":"Svalbe","year":"2019","journal-title":"Behav Brain Res"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00774_bib91","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/syn.890070305","article-title":"MK-801 inhibition of nicotinic acetylcholine receptor channels","volume":"7","author":"Amador","year":"1991","journal-title":"Synapse"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00774_bib92","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3758\/BF03337831","article-title":"Behavioral effects of MK-801 mimic deficits associated with hippocampal damage","volume":"17","author":"Robinson","year":"1989","journal-title":"Psychobiology"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00774_bib93","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/hipo.20367","article-title":"A single application of MK801 causes symptoms of acute psychosis, deficits in spatial memory, and impairment of synaptic plasticity in rats","volume":"18","author":"Manahan-Vaughan","year":"2008","journal-title":"Hippocampus"},{"key":"10.1016\/j.neurot.2025.e00774_bib94","first-page":"16","article-title":"Long-term potentiation-like visual synaptic plasticity is negatively associated with self-reported symptoms of depression and stress in healthy adults","author":"Rygvold","year":"2022","journal-title":"Front Hum Neurosci"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00774_bib95","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bbr.2011.05.017","article-title":"Gruber O.,et al. Dysfunctional long-term potentiation-like plasticity in schizophrenia revealed by transcranial direct current stimulation","volume":"224","author":"Hasan","year":"2011","journal-title":"Behav Brain Res"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00774_bib96","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1113\/jphysiol.2006.116178","article-title":"The sigma-1 receptor modulates NMDA receptor synaptic transmission and plasticity via SK channels in rat hippocampus","volume":"578","author":"Martina","year":"2007","journal-title":"J Physiol"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00774_bib97","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/S0026-895X(25)09557-4","article-title":"Direct inhibition of 5-hydroxytryptamine3 receptors by antagonists of L-type Ca2+ channels","volume":"50","author":"Hargreaves","year":"1996","journal-title":"Mol Pharmacol"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00774_bib98","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/00115550-200711000-00002","article-title":"Local anesthetics have different mechanisms and sites of action at recombinant 5-HT3 receptors","volume":"32","author":"Ueta","year":"2007","journal-title":"Reg Anesth Pain Med"},{"key":"10.1016\/j.neurot.2025.e00774_bib99","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.neuroscience.2023.03.022","article-title":"Theta\/gamma Co-modulation disruption after NMDAr blockade by MK-801 is associated with spatial working memory deficits in mice","volume":"519","author":"Abad-Perez","year":"2023","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurot.2025.e00774_bib100","doi-asserted-by":"crossref","unstructured":"Barr M.S., Rajji T.K., Zomorrodi R., Radhu N., George T.P., Blumberger D.M., et al. Impaired theta-gamma coupling during working memory performance in schizophrenia. Schizophr Res [Internet] 2017;189:104\u2013110.","DOI":"10.1016\/j.schres.2017.01.044"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00774_bib101","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1093\/cercor\/bhv177","article-title":"Spatial reference memory is associated with modulation of theta-gamma coupling in the dentate gyrus","volume":"26","author":"Bott","year":"2016","journal-title":"Cereb Cortex"},{"issue":"49","key":"10.1016\/j.neurot.2025.e00774_bib102","doi-asserted-by":"crossref","first-page":"20942","DOI":"10.1073\/pnas.0911331106","article-title":"Theta-gamma coupling increases during the learning of item-context associations","volume":"106","author":"Tort","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neurot.2025.e00774_bib103","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.conb.2014.08.001","article-title":"Theta\u2013gamma coupling in the entorhinal\u2013hippocampal system","volume":"31","author":"Colgin","year":"2015","journal-title":"Curr Opin Neurobiol"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747925002521?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747925002521?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T12:48:14Z","timestamp":1775306894000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747925002521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":103,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1878747925002521"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2025.e00774","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sigma-1-targeting multimodal compound HBK-15 reverses memory deficits and restores hippocampal plasticity under NMDA hypofunction","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2025.e00774","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00774"}}